glp 1 incontinence Effects of Glucagon like Peptide-1 agonists on patients with overactive bladder: A pilot study Potential Use of GLP-1 and

In the stratified analysis, the same results were obtained between patients receiving 750 mg a day of l-carnitine and those of 1500 mg a day (0.104 0.084 vs

And early research backs that up

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers

Once your hematocrit is back in the normal range and other causes (like sleep apnea) have been addressed or ruled out, you might be cleared to restart TRT